ESTRO 2025 - Abstract Book

S888

Clinical - Gynaecology

ESTRO 2025

Material/Methods: 28 patients with gynecological cancer were screened for malnutrition and sarcopenia at first consultation (figure 1). Usual and current weight, involuntary weight loss, height, BMI, calf circumference and dynamometry were obtained (table 1). MUST tool was used to calculate risk of malnutrition (0 = low, 1 = intermediate, ≥2 high). SARC-F questionnaire helped determine the existence of risk of sarcopenia (≥4 was an indicator of sarcopenia). Patients with low risk were reevaluated weekly, intermediate and high risk underwent early nutritional intervention. Patients at high risk were referred to the Nutrition Unit.

Results: Mean follow-up and age were 6 months and 65 years. Mean BMI was 27.05 (15.7-44.5). Median involuntary weight loss was 0.96% (0-21.42). MUST identified 4 patients (14.29%) with intermediate risk and 6 (21.43%) with high risk of malnutrition. 4 patients with MUST ≥2 had BMI >30Kg/m2. 6 patients (21.43%) were identified at risk of sarcopenia. Conclusion: Nutritional screening in patients with gynecological cancer detected a subgroup at risk of malnutrition and/or sarcopenia and made it possible to establish early nutritional intervention to reduce associated comsequences.

Keywords: Malnutrition, sarcopenia, screening